Scott N. Boyle

Insider Reports History

Location
Watertown, MA
Signature
/s/ Shagha Russell, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Scott N. Boyle:

Company Role Class Num Shares Value Price $ Report Date Ownership
C4 Therapeutics, Inc. Chief Business Officer Common Stock 107,805 $339,586 $3.15 18 Feb 2025 Direct
C4 Therapeutics, Inc. Chief Business Officer Performance Restricted Stock Units 10,500 $63,420 $6.04 07 Nov 2024 Direct
C4 Therapeutics, Inc. Chief Business Officer Stock Option (Right to Buy) 84,700 14 Feb 2025 Direct

Insider Reports Filed by Scott N. Boyle

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CCCC C4 Therapeutics, Inc. 13 Feb 2025 6 -$16,733 4 Chief Business Officer 18 Feb 2025, 16:55
CCCC C4 Therapeutics, Inc. 07 Nov 2024 3 -$6,656 4 Chief Business Officer 12 Nov 2024, 16:17
CCCC C4 Therapeutics, Inc. 16 Sep 2024 3 -$4,204 4 Chief Business Officer 17 Sep 2024, 17:12
CCCC C4 Therapeutics, Inc. 07 Mar 2024 2 $0 4 Chief Business Officer 08 Mar 2024, 19:28
CCCC C4 Therapeutics, Inc. 13 Feb 2024 3 -$11,330 4 Chief Business Officer 15 Feb 2024, 17:03
CCCC C4 Therapeutics, Inc. 18 Sep 2023 1 $0 4 Chief Business Officer 19 Sep 2023, 20:23
CCCC C4 Therapeutics, Inc. 30 Aug 2023 3 -$1,937 4 Chief Business Officer 31 Aug 2023, 17:09
CCCC C4 Therapeutics, Inc. 13 Feb 2023 2 $0 4 Chief Business Officer 15 Feb 2023, 15:45
CCCC C4 Therapeutics, Inc. 30 Jan 2023 3 -$9,507 4 Chief Business Officer 01 Feb 2023, 15:10
CCCC C4 Therapeutics, Inc. 26 May 2022 1 -$7,725 4/A Chief Business Officer 14 Jun 2022, 16:45
CCCC C4 Therapeutics, Inc. 25 May 2022 2 $0 4 Chief Business Officer 27 May 2022, 16:15
CCCC C4 Therapeutics, Inc. 16 Mar 2022 0 $0 3 Chief Business Officer 17 Mar 2022, 16:18